v3.25.4
Cover - USD ($)
12 Months Ended
Oct. 31, 2025
Feb. 13, 2026
Apr. 30, 2025
Cover [Abstract]      
Document Type 10-K    
Amendment Flag false    
Document Annual Report true    
Document Transition Report false    
Document Period End Date Oct. 31, 2025    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2025    
Current Fiscal Year End Date --10-31    
Entity File Number 000-41766    
Entity Registrant Name VITRO BIOPHARMA, INC.    
Entity Central Index Key 0000793171    
Entity Tax Identification Number 84-1012042    
Entity Incorporation, State or Country Code NV    
Entity Address, Address Line One 3200 Cherry Creek Drive South    
Entity Address, Address Line Two Suite 410    
Entity Address, City or Town Denver    
Entity Address, State or Province CO    
Entity Address, Postal Zip Code 80209    
City Area Code (855)    
Local Phone Number 848-7627    
Title of 12(g) Security Common Stock, par value $0.001 per share    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status No    
Entity Interactive Data Current No    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company false    
Entity Shell Company false    
Entity Public Float     $ 0
Entity Common Stock, Shares Outstanding   4,517,651  
ICFR Auditor Attestation Flag false    
Document Financial Statement Error Correction [Flag] false    
Entity Listing, Par Value Per Share $ 0.001    
Auditor Firm ID 206    
Auditor Opinion [Text Block] We have audited the accompanying consolidated balance sheets of Vitro Biopharma, Inc. and its subsidiaries (collectively, the “Company”) as of October 31, 2025 and 2024, and the related consolidated statements of operations, changes in stockholders’ deficit, and cash flows for the years then ended, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of October 31, 2025 and 2024, and the results of their operations and their cash flows for the years then ended, in conformity with accounting principles generally accepted in the United States of America.    
Auditor Name MaloneBailey, LLP    
Auditor Location Houston, Texas